AU2005322686B2 - Chinese hamster apoptosis-related genes - Google Patents

Chinese hamster apoptosis-related genes Download PDF

Info

Publication number
AU2005322686B2
AU2005322686B2 AU2005322686A AU2005322686A AU2005322686B2 AU 2005322686 B2 AU2005322686 B2 AU 2005322686B2 AU 2005322686 A AU2005322686 A AU 2005322686A AU 2005322686 A AU2005322686 A AU 2005322686A AU 2005322686 B2 AU2005322686 B2 AU 2005322686B2
Authority
AU
Australia
Prior art keywords
cell
sequence
cells
seq
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005322686A
Other languages
English (en)
Other versions
AU2005322686A1 (en
Inventor
Chee Furng Wong
Miranda Gek Sim Yap
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agency for Science, Technology and Research
Original Assignee
Agency for Science, Technology and Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency for Science, Technology and Research filed Critical Agency for Science, Technology and Research
Publication of AU2005322686A1 publication Critical patent/AU2005322686A1/en
Application granted granted Critical
Publication of AU2005322686B2 publication Critical patent/AU2005322686B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2005322686A 2004-12-30 2005-12-28 Chinese hamster apoptosis-related genes Ceased AU2005322686B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64033304P 2004-12-30 2004-12-30
US60/640,333 2004-12-30
PCT/SG2005/000433 WO2006071200A2 (en) 2004-12-30 2005-12-28 Chinese hamster apoptosis-related genes

Publications (2)

Publication Number Publication Date
AU2005322686A1 AU2005322686A1 (en) 2006-07-06
AU2005322686B2 true AU2005322686B2 (en) 2012-01-19

Family

ID=36615341

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005322686A Ceased AU2005322686B2 (en) 2004-12-30 2005-12-28 Chinese hamster apoptosis-related genes

Country Status (9)

Country Link
US (5) US7846894B2 (enExample)
EP (6) EP1997890A1 (enExample)
JP (1) JP5089400B2 (enExample)
KR (1) KR20070082597A (enExample)
CN (3) CN101875692A (enExample)
AU (1) AU2005322686B2 (enExample)
IL (1) IL183361A0 (enExample)
SG (1) SG158841A1 (enExample)
WO (1) WO2006071200A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013234046B2 (en) 2012-03-16 2017-09-07 University Health Network Methods and compositions for modulating Toso activity
EP2674495A1 (en) * 2012-06-14 2013-12-18 Sanofi CHO expression system
WO2014068048A1 (en) * 2012-11-05 2014-05-08 Celonic Ag Expression system
CA2917077A1 (en) 2013-07-03 2015-01-08 University Health Network Antibodies to toso
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN107630038A (zh) * 2017-09-15 2018-01-26 浙江大学 提高老年大鼠骨髓间充质干细胞移植后生存能力的方法
WO2019180607A1 (en) * 2018-03-19 2019-09-26 Centre For Cellular And Molecular Platforms A vector, a host cell and a method thereof
CN108359632A (zh) * 2018-03-30 2018-08-03 吉林冠界生物技术有限公司 Mdck细胞系、复制病毒的方法及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586206B1 (en) * 1999-09-27 2003-07-01 Genentech, Inc. Methods for making recombinant proteins using apoptosis inhibitors
US20040143111A1 (en) * 1997-04-17 2004-07-22 Incyte Corporation Novel apoptosis-associated protein

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH02500329A (ja) 1987-05-21 1990-02-08 クリエイテイブ・バイオマリキユールズ・インコーポレーテツド ターゲット化多機能蛋白質
DE68927933T2 (de) 1988-09-02 1997-08-14 Dyax Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
FI903489A7 (fi) 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
EP0816497A3 (en) * 1996-06-26 1999-12-22 Smithkline Beecham Corporation Human requiem polypeptide for apoptosis
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
GB9625283D0 (en) * 1996-12-04 1997-01-22 Janssen Pharmaceutica Nv Vertebrate homologues of unc-53 protein of c.elegans or functional eqivalents thereof and cdna sequences coding for said homologue
US6451759B1 (en) 1998-01-14 2002-09-17 The Regents Of The University Of California Noncleavable Fas ligand
AU3753099A (en) * 1998-04-21 1999-11-08 Trustees Of Boston University Novel genes and methods that modulate apoptosis
US6683168B1 (en) 1998-04-21 2004-01-27 Boston Medical Center Corporation Genes and methods that modulate apoptosis
US6015712A (en) * 1999-07-19 2000-01-18 Isis Pharmaceuticals Inc. Antisense modulation of FADD expression
US7575860B2 (en) * 2000-03-07 2009-08-18 Evans David H DNA joining method
US20040023385A1 (en) * 2002-08-05 2004-02-05 Isis Pharmaceuticals Inc. Antisense modulation of requiem expression
WO2004070025A2 (en) * 2003-02-05 2004-08-19 Juan Saus Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
CN1548054A (zh) * 2003-05-08 2004-11-24 陆爱丽 预防或治疗sars冠状病毒的药物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040143111A1 (en) * 1997-04-17 2004-07-22 Incyte Corporation Novel apoptosis-associated protein
US6586206B1 (en) * 1999-09-27 2003-07-01 Genentech, Inc. Methods for making recombinant proteins using apoptosis inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VITO, P. et al, Science, 1996, Vol. 271, pages 521-525 *

Also Published As

Publication number Publication date
CN101133156A (zh) 2008-02-27
EP2298888A1 (en) 2011-03-23
CN101875957A (zh) 2010-11-03
CN101875692A (zh) 2010-11-03
US20110318316A1 (en) 2011-12-29
EP1997890A1 (en) 2008-12-03
EP2298887A1 (en) 2011-03-23
US20110129927A1 (en) 2011-06-02
JP5089400B2 (ja) 2012-12-05
US20110318831A1 (en) 2011-12-29
IL183361A0 (en) 2007-09-20
US20110318317A1 (en) 2011-12-29
WO2006071200A2 (en) 2006-07-06
JP2008526200A (ja) 2008-07-24
US20080295190A1 (en) 2008-11-27
WO2006071200A3 (en) 2007-01-25
EP2298889A1 (en) 2011-03-23
SG158841A1 (en) 2010-02-26
KR20070082597A (ko) 2007-08-21
AU2005322686A1 (en) 2006-07-06
EP1831366A2 (en) 2007-09-12
EP2298890A1 (en) 2011-03-23
US7846894B2 (en) 2010-12-07

Similar Documents

Publication Publication Date Title
US7846894B2 (en) Chinese hamster apoptosis-related genes
Byrd et al. Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex.
JP4145314B2 (ja) 腫瘍細胞成長阻害のための組成物及び方法
Chiu et al. A caspase cleavage fragment of p115 induces fragmentation of the Golgi apparatus and apoptosis
US5955593A (en) BH3 interacting domain death agonist
EP2010565B1 (en) Method for recombinant protein production in cho cells
Holmgreen et al. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members
CA2271783A1 (en) Survivin, a protein that inhibits cellular apoptosis, and its modulation
US20090181005A1 (en) Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
WO1998022589A9 (en) Survivin, a protein that inhibits cellular apoptosis, and its modulation
Ryu et al. Apoptosis induced by human Fas-associated factor 1, hFAF1, requires its ubiquitin homologous domain, but not the Fas-binding domain
US7807783B1 (en) Methods and compositions for regulating FAS-associated apoptosis
US8354251B2 (en) Transactivation system for mammalian cells
CA2273202A1 (en) Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
US7097972B1 (en) Method and composition for regulating apoptosis
EP0900275B1 (en) Methods and reagents for modulating apoptosis
US6291648B1 (en) Antitumor protein and corresponding gene sequence isolated from matsutake mushrooms
WO2000075278A9 (en) Gene encoding nade, p75ntr-associated cell death executor and uses thereof
Yang Deletion of the GPI pre-anchor sequence in Mtf as a mechanism for generating the soluble form of the protein
Reed Yeast Genetics for Delineating Bax/Bcl Pathway of Cell Death Regulation.
WO2000017353A1 (en) Ucp4
WO2002096944A2 (en) New heterotetrameric potassium channels and uses thereof
UA74529C2 (en) CASH (CASPASE HOMOLOGUE) WITH ôDEATH-EFFECTOR" DOMAIN, MODULATORS OF FAS-RECEPTOR FUNCTIONS

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired